Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8671 |
High Similarity |
NPD37 |
Approved |
0.8625 |
High Similarity |
NPD4967 |
Phase 2 |
0.8625 |
High Similarity |
NPD4965 |
Approved |
0.8625 |
High Similarity |
NPD4966 |
Approved |
0.8606 |
High Similarity |
NPD7228 |
Approved |
0.8528 |
High Similarity |
NPD7199 |
Phase 2 |
0.8519 |
High Similarity |
NPD6234 |
Discontinued |
0.8418 |
Intermediate Similarity |
NPD1653 |
Approved |
0.8402 |
Intermediate Similarity |
NPD7240 |
Approved |
0.8383 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.8313 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.816 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8141 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8118 |
Intermediate Similarity |
NPD7054 |
Approved |
0.807 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8061 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8035 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8024 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8013 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7939 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7907 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7901 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7874 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7784 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7784 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7765 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7742 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7717 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7712 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7688 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7647 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.763 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.763 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7613 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7613 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7605 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.758 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.758 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.756 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7545 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7542 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7484 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7483 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7473 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7469 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7453 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7453 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7439 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7427 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7418 |
Intermediate Similarity |
NPD6843 |
Phase 3 |
0.7418 |
Intermediate Similarity |
NPD6841 |
Approved |
0.7418 |
Intermediate Similarity |
NPD6842 |
Approved |
0.7414 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7384 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7368 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7362 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7349 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7345 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD919 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7325 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7317 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7317 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7308 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7289 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7278 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7268 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7268 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7262 |
Intermediate Similarity |
NPD5403 |
Approved |
0.725 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7239 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7212 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7205 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7197 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7176 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.717 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7159 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7152 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7117 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7117 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7107 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7107 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7098 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7083 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7077 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7073 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7073 |
Intermediate Similarity |
NPD6099 |
Approved |
0.707 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7069 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7069 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD920 |
Approved |
0.7059 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7055 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7051 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7051 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7051 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7041 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7037 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7037 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7035 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.703 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.703 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7024 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7024 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7013 |
Intermediate Similarity |
NPD5125 |
Phase 3 |
0.7013 |
Intermediate Similarity |
NPD5126 |
Approved |
0.7006 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7982 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.6993 |
Remote Similarity |
NPD1548 |
Phase 1 |
0.6989 |
Remote Similarity |
NPD3749 |
Approved |
0.6987 |
Remote Similarity |
NPD2981 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD1608 |
Approved |
0.6983 |
Remote Similarity |
NPD5242 |
Approved |
0.6977 |
Remote Similarity |
NPD3226 |
Approved |
0.6977 |
Remote Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD2438 |
Suspended |
0.697 |
Remote Similarity |
NPD7874 |
Approved |
0.697 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD5006 |
Approved |
0.6959 |
Remote Similarity |
NPD5005 |
Approved |
0.6957 |
Remote Similarity |
NPD3268 |
Approved |
0.6943 |
Remote Similarity |
NPD6782 |
Approved |
0.6943 |
Remote Similarity |
NPD6778 |
Approved |
0.6943 |
Remote Similarity |
NPD6780 |
Approved |
0.6943
|
Remote Similarity |
NPD6777 |
Approved |